Eli Lilly https://www.reuters.com/markets/companies/LLY.N” target=”_blank” rel=”noopener”>(LLY.N) on Tuesday raised its annual forecasts after beating estimates for quarterly results, driven by strong demand for its new diabetes drug Mounjaro, ahead of a decisi…
Read More
About The Author
